COVID-19 Rapid POC Antigen Test, Box of 20
iRemedy has available for immediate shipment the CareStart COVID-19 Antigen Rapid Point of Care test kits. Get results in ten minutes. For use by healthcare professionals in point-of-care settings. Very affordable. No separate analyzer equipment needed. Authorized by the FDA for emergency use.
Provide an important service to your patients, essential workers, government agencies, educators and others who need information relating to their exposure to or infection of COVID-19.
With the second wave of COVID-19 infections underway, the demand for testing solutions has never been higher. The CareStart test kit from iRemedy can be an important part of providing this service to your community.
This item may take up to 10 business days to ship.
The CareStart™ COVID-19 Antigen is intended for use by medical professionals or trained operators who are proficient in performing tests and trained clinical laboratory personnel or individuals trained in point of care settings. The CareStart™ COVID-19 Antigen is only for use under the Food and Drug Administration’s Emergency Use Authorization.
The CareStart™ COVID-19 Antigen test is a lateral flow immunochromatographic assay intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasopharyngeal swab specimens directly collected, or collected in BD universal transport media, from individuals suspected of COVID-19 by their healthcare provider within five days of symptom onset. Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, that meet the requirements to perform moderate, high or waived complexity tests.
This test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.